Preferred Reporting Items for a Systematic Review and Meta-analysis of Diagnostic Test Accuracy Studies: The PRISMA-DTA Statement | JAMA - Journal of the American Medical Association | 2018 | 1K |
Hypertension Canada's 2018 Guidelines for Diagnosis, Risk Assessment, Prevention, and Treatment of Hypertension in Adults and Children | Canadian Journal of Cardiology | 2018 | 348 |
High-Density Proximity Mapping Reveals the Subcellular Organization of mRNA-Associated Granules and Bodies | Molecular Cell | 2018 | 331 |
Genetic architecture: the shape of the genetic contribution to human traits and disease | Nature Reviews Genetics | 2018 | 219 |
Safety and efficacy of subcutaneous tocilizumab in systemic sclerosis: results from the open-label period of a phase II randomised controlled trial (faSScinate) | Annals of the Rheumatic Diseases | 2018 | 172 |
The vaccine hesitancy scale: Psychometric properties and validation | Vaccine | 2018 | 142 |
Signaling Pathways Involved in the Regulation of mRNA Translation | Molecular and Cellular Biology | 2018 | 138 |
Neurofeedback with fMRI: A critical systematic review | NeuroImage | 2018 | 136 |
Differential regulation of PD-L1 expression by immune and tumor cells in NSCLC and the response to treatment with atezolizumab (anti-PD-L1) | Proceedings of the National Academy of Sciences of the United States of America | 2018 | 128 |
Life-Course Genome-wide Association Study Meta-analysis of Total Body BMD and Assessment of Age-Specific Effects | American Journal of Human Genetics | 2018 | 119 |
Caspase-1 inhibition alleviates cognitive impairment and neuropathology in an Alzheimer's disease mouse model | Nature Communications | 2018 | 117 |
Assessment of the genetic and clinical determinants of fracture risk: genome wide association and mendelian randomisation study | BMJ, The | 2018 | 114 |
A framework for selection of blood-based biomarkers for geroscience-guided clinical trials: report from the TAME Biomarkers Workgroup | GeroScience | 2018 | 111 |
Phase 2 study of pembrolizumab in advanced small-cell lung cancer (SCLC): KEYNOTE-158. | Journal of Clinical Oncology | 2018 | 100 |
Angiotensin converting enzyme inhibitors and risk of lung cancer: population based cohort study | BMJ, The | 2018 | 94 |
SGLT-2 inhibitors and the risk of infections: a systematic review and meta-analysis of randomized controlled trials | Acta Diabetologica | 2018 | 91 |
Cardiovascular disease and COPD: dangerous liaisons? | European Respiratory Review | 2018 | 87 |
Combining discovery and targeted proteomics reveals a prognostic signature in oral cancer | Nature Communications | 2018 | 81 |
Epidemiology of pain and relation to psychiatric disorders | Progress in Neuro-Psychopharmacology and Biological Psychiatry | 2018 | 80 |
Lower Risk of Death With SGLT2 Inhibitors in Observational Studies: Real or Bias? | Diabetes Care | 2018 | 78 |
477. Trends in the Incidence of Community-Associated and Healthcare-Associated Clostridium difficile Infections in Quebec Over a 7-Year Period (2008–2015) | Open Forum Infectious Diseases | 2018 | 78 |
243. Prioritization of Antibiotic Administration for STAT Orders in the Septic Patient: A Retrospective Analysis | Open Forum Infectious Diseases | 2018 | 78 |
UTILITY OF A GENERAL PROGNOSTIC SCORE IN IDENTIFYING PATIENTS WITH POOR OUTCOMES AFTER AORTIC VALVE REPLACEMENT | Innovation in Aging | 2018 | 78 |
DIPG-06. IDENTIFICATION OF GENES FUNCTIONALLY INVOLVED IN THE DETRIMENTAL EFFECTS OF MUTANT HISTONE K27M-H3.3 USING DROSOPHILA MELANOGASTER | Neuro-Oncology | 2018 | 78 |
Genome-wide analyses identify a role for SLC17A4 and AADAT in thyroid hormone regulation | Nature Communications | 2018 | 75 |